These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1401222)

  • 21. [Amyloidosis associated with chronic hemodialysis. The prognostic significance of beta 2-microglobulin changes in patients with terminal chronic kidney failure treated by repeated hemodialysis].
    Manasia M; Meseşan M; Gherman-Căprioară M; Malide D; Paţiu IM; Pârvu L; Vlăduţiu D; Spânu CS
    Med Interna; 1991; 43(1-2):129-34. PubMed ID: 1670118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Beta 2-microglobulin-induced amyloidosis. A new complication of long-term hemodialysis].
    Ritz E; Bommer J; Zeier M
    Dtsch Med Wochenschr; 1988 Feb; 113(5):190-6. PubMed ID: 3276494
    [No Abstract]   [Full Text] [Related]  

  • 23. Intervertebral disc amyloidosis: histochemical, immunohistochemical and ultrastructural observations.
    Mihara S; Kawai S; Gondo T; Ishihara T
    Histopathology; 1994 Nov; 25(5):415-20. PubMed ID: 7868081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta 2 microglobulin haemodialysis related amyloidosis: distinctive gross features of gastrointestinal involvement.
    Shimizu M; Manabe T; Matsumoto T; Monobe Y; Hirokawa M; Moriya T; Iida M
    J Clin Pathol; 1997 Oct; 50(10):873-5. PubMed ID: 9462276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixed systemic amyloidosis in a patient receiving long term haemodialysis.
    Fernandez-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Hernanz-Mediano W
    J Clin Pathol; 1994 Jun; 47(6):560-1. PubMed ID: 8063944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dialysis-related amyloidosis of the tongue.
    Yusa H; Yoshida H; Kikuchi H; Onizawa K
    J Oral Maxillofac Surg; 2001 Aug; 59(8):947-50. PubMed ID: 11474463
    [No Abstract]   [Full Text] [Related]  

  • 27. Synovial amyloid in chronic haemodialysis contains beta 2 microglobulin.
    Bruckner FE; Burke M; Pereira RS; Eisinger AJ; Bending M; Kwan J; Osman AK; Watson B
    Ann Rheum Dis; 1987 Aug; 46(8):634-7. PubMed ID: 3310929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta 2-microglobulin deposition in bone in chronic renal failure.
    Onishi S; Andress DL; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int; 1991 May; 39(5):990-5. PubMed ID: 2067215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic involvement of dialysis-amyloidosis.
    Campistol JM; Solé M; Muñoz-Gomez J; Lopez-Pedret J; Revert L
    Am J Nephrol; 1990; 10(5):389-96. PubMed ID: 2080789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visceral involvement of dialysis amyloidosis.
    Campistol JM; Cases A; Torras A; Soler M; Muñoz-Gómez J; Montoliu J; López-Pedret J; Revert L
    Am J Nephrol; 1987; 7(5):390-3. PubMed ID: 3434597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and immunohistochemical studies of synovial amyloid in chronic renal failure].
    Voigt C; Saeger W; Schneider M
    Pathologe; 1990 Nov; 11(6):332-5. PubMed ID: 2290790
    [No Abstract]   [Full Text] [Related]  

  • 33. Generalized amyloidosis from beta 2-microglobulin, with caecal perforation after long-term haemodialysis.
    Zhou H; Pfeifer U; Linke R
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(4):349-53. PubMed ID: 1949616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteo-articular manifestations of amyloidosis.
    M'bappé P; Grateau G
    Best Pract Res Clin Rheumatol; 2012 Aug; 26(4):459-75. PubMed ID: 23040361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New amyloidosis disease associated with dialysis: accumulation of beta-2-microglobulin into joints and bones].
    Kunelius P; Nurminen J; Kunelius R
    Duodecim; 1990; 106(5):427-31. PubMed ID: 1670111
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dialysis-associated amyloidosis. Part 1: Biochemistry, clinical aspects, roentgen morphology].
    Rieden K; Ritz E; Post K; Barth HP; Haufe S; Wannenmacher M
    Bildgebung; 1993 Jun; 60(2):63-7. PubMed ID: 8358214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subcutaneous deposition of beta 2-microglobulin amyloid in a long-term haemodialysis patient.
    Athanasou NA; Chaplin AJ; Oliver DO
    Nephrol Dial Transplant; 1990; 5(10):878-81. PubMed ID: 2128384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular involvement and cell damage in experimental AA and clinical beta(2)-microglobulin amyloidosis.
    García-García M; Mourad G; Durfort M; García-Valero J; Argilés A
    Nephrol Dial Transplant; 2002 Aug; 17(8):1450-6. PubMed ID: 12147793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Amyloidosis in hemodialysis patients].
    Bardin T; Zingraff J; Benoît J; Kuntz D; Drüeke T
    Presse Med; 1987 May; 16(18):907-10. PubMed ID: 2954121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
    Niwa T
    Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.